Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P351 | DOI: 10.1530/endoabs.110.P351

ECEESPE2025 Poster Presentations Diabetes and Insulin (143 abstracts)

CGM as a useful tool providing deeper insights into the glucose metabolism of patients with transfusion dependent b-thalassemia

Iskra Modeva 1 , 2 , Atanas Banchev 3 , 4 , Margarita Archinkova 2 , 5 & Iva Stoeva 1 & 6


1University Pediatric Hospital "Prof. Ivan Mitev", Screening and Functional Endocrine Diagnostics, Sofia, Bulgaria; 2Medical University, Sofia, Bulgaria; 3National Haematology Hospital, Sofia, Bulgaria; 4Expert center for thalassemia, University Hospital "Tzaritza Giovanna - ISUL", Sofia, Bulgaria; 5University Pediatric Hospital "Prof. Ivan Mitev", Pediatric Endocrinology and Metabolic Diseases, Sofia, Bulgaria; 6State University “Professor Assen Zlatarov, Faculty of Medicine, Burgas, Bulgaria


JOINT2868

Background: The iron overload occurring in patients with transfusion-dependent B-thalassemia causes a wide range of endocrine disorders, one of the most common being glucose dysregulation. Both insulin deficiency and resistance are reported in these patients. Current recommendations require assessment of glucose abnormalities by testing fasting blood glucose (BG) and performing oral glucose tolerance tests (oGTT) annually after a certain age. A new promising method for determining glucose disorders is the use of continuous glucose monitoring system (CGM).

Case reports: We present three cases of patients with transfusion-dependent B-thalassemia (TDT) with high ferritin levels (above 1000 ng/mL despite of the chelating therapy) and glucose dysregulation. Fasting blood glucose and extended oGTT were conducted to evaluate the glucose homeostasis along with the calculation of HOMA-IR. CGM (Dexcome One) was applied to each of them for a period of one week. MRI was conducted to evaluate the iron overload in the liver and pancreas. The first patient (14 years, male) had normal HOMA-Ir = 0. 88, but oGTT showed pronounced hyperinsulinism and impaired glucose tolerance – BG at 120’- 9. 2 mmol/l. CGM data showed postprandial glucose elevation up to 15. 3 mmol/l and mean BG 6. 2 mmol/l. The second patient (14 years, female) had insulin resistance according to HOMA-Ir = 3. 16, and normal BG and insulin levels during oGTT but the CGM showed postprandial BG up to 12. 5 mmol/l and mean blood glucose 8. 01 mmol/l. The third patient (8 years, female) had normal HOMA-Ir = 0. 7 and insulin levels during oGTT, no hyperglycemia. Three symptomatic episodes of hypoglycemia were observed with BG 3. 1, 2. 5 and 2. 0 mmol/l – two of them during the oGTT and one later the same day. CGM data showed postprandial glucose elevation up to 13 mmol/l, mean BG 6. 1 mmol/l.

Conclusions: The use of CGM seems to be more useful for diagnosing glucose dysregulation in patients with TDT than fasting BG and oGTT alone. More investigations and a longer follow up are needed.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches